Position in RGNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,053,629
+$1,754,928 QoQ
Shares Held
421,839
+7.2% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. RGNX ranks #164 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,053,629 | 421,839 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,298,701 | 393,640 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,381,120 | 373,689 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,869,743 | 401,010 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,284,654 | 400,080 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,910,906 | 407,120 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,596,466 | 465,261 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,118,981 | 487,987 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $5,057,323 | 432,250 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $9,097,707 | 431,785 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,019,573 | 446,773 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,078,374 | 430,035 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,289,431 | 414,679 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,760,624 | 410,398 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,728,561 | 428,949 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,902,437 | 488,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,450,914 | 423,114 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,774,346 | 415,015 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,943,344 | 426,402 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $20,319,376 | 484,718 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,580,399 | 478,260 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $14,965,589 | 438,745 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $17,723,601 | 390,732 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $10,978,826 | 398,940 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $15,810,895 | 429,294 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $13,287,616 | 410,365 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||